A Study of the Carbohydrate-to-Insulin Ratio in Pregnant Women with Type 1 Diabetes on Pump Treatment
Authors:
- 1 June 2016
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 18 (6) , 360-365
Abstract
Aim: The aim of this study was to assess carbohydrate (CHO)-to-insulin ratio (CHO/IR) values in pregnant women with type 1 diabetes and to describe differences in CHO/IR across each week of pregnancy. Materials and Methods: This was a multicenter, retrospective, observational study (2006–2012) of 101 white pregnant women with a mean age of 32 (range, 18–43) years who had type 1 diabetes and were under continuous subcutaneous insulin infusion (CSII) therapy. These patients had the following characteristics: type 1 diabetes duration was 1 year (range, 1–31 years), the pregestational glycosylated hemoglobin level was 6.9% (range, 6.8–12.1%), the median weight gain during pregnancy was 14 kg (−3; 25 kg), with delivery at 37 weeks (range, 30–40 weeks), and the child had a birth weight of 3.530 kg (range, 1.480–5.250 kg). The CHO/IR was measured by dividing the CHO (in g) of each meal by insulin unit injected to acquire and maintain the following glycemic targets: fasting Results: The CHO/IR decreased on average from 9.6 (5–18) to 5.4 (2.3–8) at breakfast, from 10 (3.5–16) to 8.4 (3.0–17.8) at lunch, and from 12.5 (8–20) to 6.1 (4.2–12) at dinner. The CHO/IR calculated using the “500 rule” decreased from 14.3 (10–20.3) to 8.6 (4.1–15.9). Using the “300 rule,” the ratios decreased from 8.5 (6–12.1) to 5.2 (2.4–9.5). The bivariate correlation between the values calculated more appropriate values using the “300 rule” for breakfast and the “500 rule” for lunch and dinner across all weeks of pregnancy. Conclusions: CHO/IR reduction in pregnancy is likely due to an increase in insulin resistance.Keywords
This publication has 20 references indexed in Scilit:
- The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With DiabetesDiabetes Care, 2013
- Insulin pump dosing across gestation in women with well-controlled type 1 diabetes mellitusAmerican Journal of Obstetrics and Gynecology, 2012
- Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine–MDI)Diabetes & Metabolism, 2011
- Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 DiabetesNew England Journal of Medicine, 2010
- Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of directionDiabetologia, 2009
- Continuous Glucose Monitoring During PregnancyDiabetes Technology & Therapeutics, 2009
- New modalities in the treatment of pregnancies complicated by diabetes: Drugs and devicesSeminars in Fetal and Neonatal Medicine, 2009
- Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trialBMJ, 2008
- Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesDiabetes Care, 2004
- Hypoglycemia: The price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitusObstetrics & Gynecology, 1995